Igc Pharma Inc
(IGC)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
| 03-2010 | 03-2009 | 03-2008 | 03-2007 | 03-2006 | |
| Sales | 17,898 | 35,339 | 2,188 | 0 | 0 |
| Cost of Goods | 15,672 | 27,180 | 1,783 | N/A | N/A |
| Gross Profit | 2,226 | 8,159 | 405 | N/A | N/A |
| Operating Expenses | 6,890 | 6,030 | 1,209 | 0 | 536 |
| Operating Income | -3,992 | 2,308 | -21 | N/A | -536 |
| Interest Expense | 1,222 | 1,754 | 1,945 | 104 | 6 |
| Other Income | -2,704 | 1,176 | -3,349 | 2,407 | 142 |
| Pre-tax Income | -7,918 | 1,731 | -5,315 | 2,303 | -399 |
| Income Tax | -3,110 | 1,535 | 76 | 785 | 45 |
| Net Income Continuous | -4,808 | 195 | -5,386 | 1,518 | -444 |
| Minority Interests | -19 | 717 | N/A | N/A | N/A |
| Net Income | $-4,789 | $-522 | $-5,386 | $1,518 | $-444 |
| EPS Basic Total Ops | -4.20 | -0.50 | -6.10 | 1.10 | -1.40 |
| EPS Basic Continuous Ops | -4.17 | 0.19 | -6.29 | 1.09 | -1.39 |
| EPS Diluted Total Ops | -4.20 | -0.50 | -6.10 | 1.10 | -1.40 |
| EPS Diluted Continuous Ops | -4.17 | 0.19 | -6.29 | 1.09 | -1.39 |
| EBITDA(a) | $-3,032 | $3,184 | $4,340 | $29 | $-536 |